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Original Article
Laser in situ keratomileusis (LASIK), laser-assisted sub-
epithelial keratectomy (LASEK), and photorefractive kera-
tectomy (PRK) are effective surgical techniques for the 
correction of myopia, myopic astigmatism, and mild to 
moderate hypermetropia. Although the predictability of 
these techniques has improved, the precise refractive out-
come is not always guaranteed because of different re-
sponses of living tissue to laser ablation [1]. The reported 
rates of myopic regression that require retreatment ranged 
from 6% to 14% for up to 1 year following the surgical 
procedure, and from 20% to 27% for longer follow-up pe-
riods [2,3]. However, recent studies have indicated that the 
rates have declined [4,5]. Higher initial corrections, the de-
gree of astigmatism, and advanced age of patients are 
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known to increase the odds of requiring retreatment [6]. 
Although not all of the mechanisms involved in myopic re-
gression have been elucidated, the number of patients who 
require retreatment for myopic regression after primary 
refractive surgery has decreased. The reported decrease 
has been attributed to an enlarged optical zone, the devel-
opment of laser technology, and improved postoperative 
wound management. However, some patients still experi-
enced myopic regression after the performance of primary 
refractive surgery. Further, retreatment planning following 
primary refractive surgery is dependent on the individual 
needs of each patient.
Retreatment tends to be less predictable compared with 
primary ablation because of difficulties related to analysis 
of the refractive state, unpredictable rates of wound heal-
ing, and corneal irregularities induced by previous ablation 
procedures. Previous studies have reported that the combi-
nation of corneal wavefront and topographic aspheric 
treatments has been used successfully to treat eyes that 
have undergone previous refractive surgeries [5,7].
Optimized prolate ablation (OPA) employs wavefront 
aberrometry and corneal topography to treat preexisting 
spherical aberrations and to maintain the preoperative cor-
neal asphericity (Q value) [8,9]. As improved outcomes had 
been achieved in previous studies with the combined ap-
plication of the corneal wavefront and topographic aspher-
ic treatments, we endeavored to assess clinical outcomes 
following application of the OPA retreatment method. In 
the current study, we investigated the clinical efficacy of 
an OPA procedure for the treatment of persistent refractive 
errors following previous refractive surgery.
Materials and Methods
In this retrospective study, we evaluated patients who 
had undergone retreatment OPA following previous 
LASIK, LASEK, or PRK surgery. The study was conduct-
ed in accordance with the Declaration of Helsinki, and 
surgical procedures were conducted after all patients par-
ticipated in a thorough preoperative discussion of the risks 
and benefits of OPA and informed consent was obtained.
Inclusion criteria for patients who had undergone previ-
ous LASIK, LASEK, or PRK between 1997 and 2012 in-
cluded an age greater than 20 years and myopia measure-
ments less than or equal to –3.50 manifest refraction 
spherical equivalent (MRSE) diopters (D). Patients who 
had active systemic ocular disease or who underwent pre-
vious ocular surgery other than the aforementioned prima-
ry refractive surgeries were excluded from the study. All 
patients were symptomatic and had residual refractive er-
rors. 
All patients underwent a preoperative ophthalmic evalu-
ation, and uncorrected distance visual acuity (UDVA), 
corrected distance visual acuity (CDVA), manifest refrac-
tion, corneal topography, wavefront aberrometry, modula-
tion transfer function (MTF), point spread function (PSF), 
slit-lamp biomicroscopy, tonometry, and fundus measure-
ments were obtained postoperatively at 1, 3, and 6 months. 
Corneal haze was assessed on a scale from 0 to 4 accord-
ing to the method proposed by Fantes et al. [10]. Corneal 
topography and wavefront aberrometry were measured on 
the same optical axis using an OPD-Scan III wavefront ab-
errometer (Nidek, Tokyo, Japan), following the application 
of tropicamide 0.5%-phenylephrine 0.5% eye drops 
(Mydrin-P; Santen, Osaka, Japan) and the subsequent dila-
tion of the pupil to 6.0 mm. All wavefront measurements 
were performed to the eighth Zernike order. The device 
software separated corneal and internal aberrations to 
evaluate the effects of the optical elements in the visual 
system. Corneal asphericity (Q value) was measured by 
software-simulated corneal topography. The objective vi-
sual quality was assessed using an MTF graph, which re-
vealed the degree of contrast transfer at different spatial 
frequencies by calculating the area ratio and the ratio of 
the area under the MTF graph covered by the vertical and 
horizontal axes to the area under the normal eye curve. 
PSF was also calculated using the Strehl ratio, which is the 
ratio of the PSF value to the theoretical diffraction limit. 
All patients underwent treatment by one surgeon (BJC) 
using the EC 5000 CXII excimer laser platform (Nidek). 
Manifest refraction, corneal topographic data, and wave-
front data obtained from the OPD-Scan III were consid-
ered when designing the ablation procedure. All data were 
transferred to the Optimized Prolate Ablation Software 
(ver. 1.00, Nidek) for treatment planning. The ablation de-
sign was established automatically using the software, by 
setting the value of the postoperative ocular spherical ab-
erration to zero. The software did not target to correct ocu-
lar coma and trefoil aberration. The surgeon adjusted the 
degree of refractive correction for age, pretreatment mani-
fest refraction, and CDVA. The eyes of each patient were 
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prepared in a sterile fashion, and a topical anesthetic 
(proparacaine hydrochloride 0.5%, Alcaine; Alcon, Fort 
Worth, TX, USA) was instilled. Following the application 
of the Carones LASEK Pump OZ Chamber (9.0 mm in di-
ameter; ASCIO, Copenhagen, Denmark), the cone was 
filled with 20% alcohol solution mixed with Liquifilm 
tears (Polyvinyl Alcohol 1.4%; Allergan, Irvine, CA, USA). 
The alcohol solution was flushed out for 40 seconds after 
instillation using a cold balanced salt solution. To detect 
torsion error, the image of the patient’s iris was compared 
with the image acquired using the OPD-Scan III device. If 
the torsion error was greater than 2°, the patient’s head was 
repositioned in an attempt to decrease the error. The opti-
cal zone was established using the Optimized Prolate Ab-
lation software, and covered the entire scotopic pupil di-
ameter, considering the ablation depth. The transition zone 
was determined to be 1.5 mm larger than the optical zone 
diameter. The mean optical zone and transition zone were 
6.3 mm and 7.9 mm, respectively. A 14-ring-shaped filter 
paper disc saturated with 0.02% mitomycin C was applied 
on the cornea for 15 seconds to prevent contact with the 
central portion of the cornea. Irrigation with cold balanced 
salt solution was performed for 15 seconds following the 
removal of the paper disc [11,12]. A therapeutic soft contact 
lens was then applied to ensure complete epithelial heal-
ing. Finally, a standardized regimen of topical steroids and 
antibiotics was recommended for each patient. 
Postoperative UDVA and CDVA, ocular wavefront aber-
rations, corneal spherical aberration, corneal asphericity, 
MTF, and PSF were compared to preoperative (before re-
treatment) values using analysis of variance and Bonfer-
roni tests. A p-value less than 0.05 was considered statisti-
cally significant. All analyses were performed using the 
SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA).
Table 1. Preoperative and postoperative follow-up parameters
Parameter
Preoperative Postoperative
p-value*
1 mon 3 mon 6 mon
UDVA (logMAR)  0.42 ± 0.29  0.01 ± 0.09† 0.00 ± 0.07† –0.02 ± 0.08† 0.000
CDVA (logMAR) –0.08 ± 0.05 –0.03 ± 0.05† –0.06 ± 0.04 –0.08 ± 0.05 0.000
Sphere (D) –2.03 ± 0.68  0.16 ± 0.61† –0.01 ± 0.69†  –0.11 ± 0.64† 0.000
Cylinder (D)  0.30 ± 0.40 0.35 ± 0.31 0.36 ± 0.31 0.32 ± 0.26 0.904
MRSE (D) –2.18 ± 0.67 –0.02 ± 0.61† –0.19 ± 0.70† –0.27 ± 0.64† 0.000
HOA (mm) 0.68 ± 0.21 0.73 ± 0.23 0.75 ± 0.19 0.75 ± 0.16 0.528
Total coma (µm) 0.38 ± 0.20 0.50 ± 0.21  0.54 ± 0.19†  0.54 ± 0.16† 0.010
Total trefoil (µm) 0.32 ± 0.19 0.38 ± 0.24 0.35 ± 0.19 0.37 ± 0.20 0.824
Ocular SA (µm) 0.33 ± 0.21  0.17 ± 0.14† 0.24 ± 0.10 0.25 ± 0.12 0.006
Corneal SA (µm) 0.65 ± 0.21 0.55 ± 0.15 0.59 ± 0.13 0.58 ± 0.12 0.190
Corneal asphericity 0.68 ± 0.40 0.80 ± 0.47 0.87 ± 0.42 0.83 ± 0.40 0.446
Corneal haze  - 0.11 ± 0.23 0.01 ± 0.04 0.04 ± 0.20 -
PSF Strehl ratio 0.019 ± 0.011 0.026 ± 0.015 0.023 ± 0.012 0.021 ± 0.011 0.271
Total MTF ratio (%) 18.2 ± 4.0  42.6 ± 13.5†  40.0 ± 11.1†  40.1 ± 11.7† 0.000
HO MTF‡ ratio (%) 45.6 ± 11.8 51.7 ± 11.0  48.2 ± 8.50 45.4 ± 8.30 0.108
Values are presented as mean ± standard deviation.
UDVA = uncorrected distance visual acuity; logMAR = logarithm of the minimum angle of resolution; CDVA = corrected distance vi-
sual acuity; D = diopters; MRSE = manifest refraction spherical equivalent; HOA = higher-order aberrations; SA = spherical aberration; 
PSF = point spread function; MTF = modulation transfer function; HO = higher-order.
*Difference between groups. The p-values were calculated using analysis of variance and Bonferroni correction; †Statistically significant 
difference compared to preoperative value; ‡Simulated using only higher-order aberrations.
Spherical aberrations are reported for the entire eye (ocular) and cornea at 6.0-mm diameter to the eighth Zernike order. Corneal asphe-
ricity, commonly referred to as the Q value, is reported for a 6.0-mm diameter.
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Results
Patients
The study included 24 eyes from 15 enrolled patients, 
including eight males and seven females. The mean patient 
age was 33 years (range, 25 to 45 years). Twelve eyes (eight 
patients) had undergone a previous LASIK procedure, nine 
eyes (five patients) a previous LASEK procedure, and three 
eyes (two patients) had undergone PRK. The mean interval 
between the first refractive procedure and retreatment was 
108 ± 60 months (range, 12 months to 20.9 years). No in-
traoperative or postoperative complications were detected.
Refractive and visual acuity outcomes
The mean MRSE before primary surgery was –6.67 ± 
1.98 D (range, –2.75 to –10.50 D), and the mean cylinder 
was 0.81 ± 0.84 D (range, 0.00 to 2.58 D). In addition, the 
residual stromal bed measurement was 312 ± 38.3 µm 
(range, 271 to 378 µm). Preoperatively, and 1, 3 and 6 
months post performance of the surgical procedures, the 
mean MRSE values were –2.18 ± 0.67 D, –0.02 ± 0.61 D, 
–0.19 ± 0.70 D, and –0.27 ± 0.64 D, respectively (Table 1). 
The reduction in MRSE was statistically significant at all 
postoperative time points when compared to preoperative 
measurements (p < 0.005). Postoperative astigmatism was 
0.32 ± 0.26 D (range, 0.00 to 0.75 D) at 6 months, which re-
mained statistically unchanged from preoperative astigma-
tism measurements of 0.30 ± 0.40 D (range, 0.00 to 1.25 D) 
(Fig. 1). Postoperative changes in spherical equivalent and 
astigmatic error are shown in Figs. 2 and 3, respectively. A 
statistically significant increase (p < 0.001) was detected in 
the mean UDVA from 0.42 ± 0.29 logarithm of the mini-
mum angle of resolution (logMAR) preoperative measure-
ments (range, 0.10 to 1.00 logMAR) to –0.02 ± 0.08 log-
MAR postoperative measurements (20 / 50 to 20 / 20 as 
Snellen equivalent) acquired at 6 months (range, –0.18 to 
0.15 logMAR). Twenty eyes (83.3%) had a UDVA of 20 / 
20 or better in terms of efficacy (Fig. 4). CDVA exhibited 
no statistical change between baseline (postoperative) and 
6 months postoperatively. For the entire follow-up period, 
no eye lost two or more CDVA lines, and 23 eyes (95.8%) 
maintained or gained CDVA lines (Fig. 5). Fifteen eyes 
(62.5%) were within ±0.50 D of attempted correction, and 
20 eyes (83.3%) were within ±1.00 D 6 months postopera-
tively (Fig. 6).
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Wavefront aberrations
No significant differences were detected in the mean 
preoperative root mean square of ocular higher-order aber-
rations (HOA) after the OPA retreatment at all postopera-
tive time points (Fig. 7A). The mean ocular spherical aber-
ration decreased from 0.33 ± 0.21 µm preoperatively to 0.17 
± 0.14 µm (p < 0.005) at 1 month postoperatively, but ex-
hibited no statistically significant postoperative change at 3 
or 6 months when compared to baseline (Fig. 7B). While 
the mean coma aberration increased significantly at 3 and 
6 months postoperatively, no statistically significant chang-
es were noted in the mean trefoil aberration (Fig. 7C and 
7D). Corneal spherical aberration remained unchanged at 
all postoperative time points (Fig. 7B).
Corneal asphericity and haze
Corneal asphericity (Q value) was maintained after OPA 
retreatment at all postoperative time points; however, the 
Q value tended to increase after OPA retreatment. Corneal 
haze after retreatment remained minimal. 
Objective visual quality
The mean MTF representing the area ratio increased 
significantly at all postoperative time points compared to 
the preoperative values (Table 1). MTF simulated with the 
eye corrected for lower-order aberrations (e.g., sphere and 
cylinder) and the higher-order (HO) MTF exhibited no sig-
nificant changes after retreatment. PSF presented as a Stre-
hl ratio, and the ratio of the PSF value to the theoretical 
diffraction limit remained unchanged postoperatively.
Discussion
The essential advantages of OPA are to minimize the in-
duction of higher order aberrations and to maintain a pro-
late shape of cornea. By utilizing both wavefront aberrom-
etry and corneal topography, reducing the induced higher 
order aberrations while maintaining corneal asphericity 
was reported to be successful, and clinical outcomes of 
these trials were also reported to be promising in the liter-
ature. Spherical aberrations and HOAs disturbing visual 
quality could be reduced [13,14]. Halo and glare were re-
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ported to also be decreased [15]. 
The results of the current study indicate that OPA is an 
effective and predictable treatment for the correction of 
residual refractive errors following LASIK, LASEK, and 
PRK procedures. UDVA changed from 20 / 50 preopera-
tively to 20 / 20 postoperatively, and the spherical equiva-
lent was significantly reduced (p < 0.005) at all postopera-
tive time points evaluated. Further, visual outcomes in the 
current study were similar or superior to those from previ-
ous investigations involving corneal wavefront retreatment 
[5,16]. The mean refractive astigmatism remained un-
changed after OPA retreatment, while the preoperative 
range of astigmatism decreased in the 6 months following 
the performance of the surgical procedure. Further studies 
involving the investigation of OPA retreatment for astig-
matism would be helpful to assess OPA efficacy and safety 
in astigmatism retreatment patients. 
In our study, the predictability (±0.50 D from intended 
refraction) was 62.5%. Other investigations have reported 
a predictability of 76% for wavefront-guided ablations, 
91% for topography-guided ablations, and 100% when pro-
late ablation was applied as the primary treatment [13,17]. 
Compared to the application of the same OPA laser abla-
tion pattern in virgin cornea, pretreated corneas exhibited 
several drawbacks. Corneal surface irregularities after pri-
mary laser treatment, or flap making and subclinical de-
centration may impede accurate preoperative evaluation 
for treatment planning and precise ablation. Moreover, al-
tered corneal wound healing responses are likely explana-
tions for limited OPA retreatment predictability. 
In this study, corneal haze, one of the complications re-
sulting from corneal ablation, was not apparent in any pa-
tients that underwent OPA retreatment. Corneal micro-ir-
regularities have been reported to be one of the possible 
causes of corneal opacity after refractive surgery [18,19]. 
After laser ablation, collagen fibers newly synthesized to 
cover the irregular surface, are known to contribute to the 
development of corneal opacity, refractive errors, and the 
induction of HOA [20]. In our surgical procedure, photo-
therapeutic keratectomy surface smoothing and applica-
tion of mitomycin C might have prevented corneal opacity. 
Eyes treated with additional phototherapeutic keratectomy 
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smoothing, which was performed to remove corneal mi-
cro-irregularities, were reported to be less likely to develop 
corneal haze and collagen fibers [21-23].
 Although factors causing regression after LASEK, 
LASIK, and PRK are not clearly understood, previous in-
vestigations have revealed that regression might be caused 
by molecular memory in the corneal collagen fibers, or by 
stromal remodeling, corneal ectasia, corneal hydration, the 
effect of intraocular pressure on the thinned cornea, or by 
compensatory epithelial hyperplasia [6,24]. Prior reports 
have likewise indicated that variability in corneal wound 
healing, including keratocyte apoptosis, biomechanical 
properties, and other factors might contribute to the appar-
ent changes [25,26]. Further, compared to initial treat-
ments, secondary laser treatments might induce atypical or 
unpredictable corneal wound healing. 
Refractive results remained stable until 6 months after 
OPA retreatment. In addition, the safety of the procedure 
was demonstrated by the postoperative loss of no more 
than two CDVA lines at 6 months. In one patient, postop-
erative CDVA decreased from 30 / 20 to 25 / 20 in con-
junction with the loss of one CDVA line at 6 months. The 
patient was a 34-year-old female who had undergone pri-
mary LASIK surgery 13.4 years prior to retreatment. Her 
refractive error measurements before the primary LASIK 
surgery and before the retreatment were –6.34 and –2.25, 
respectively. However, the patient exhibited no astigmatic 
error before retreatment. Six months following retreat-
ment, her refractive error was –0.50, and her UDVA had 
increased from 20 / 40 to 25 / 20. While ocular and corneal 
spherical aberrations decreased and total MTF increased 6 
months postoperatively, total HOA, trefoil, and coma aber-
ration measurements were increased. Thus, a possible ex-
planation for decreased CDVA might be the increase in to-
tal HOA, trefoil, and coma aberration. 
The Q value, the coefficient of asphericity, is one of the 
coefficients used to express the conic shape factor [27,28]. 
However, corneal topography revealed no statistically sig-
nificant changes in corneal asphericity (Q value) at any 
time point after OPA retreatment. Corneal spherical aber-
rations tended to decrease after OPA retreatment, but the 
changes were not statistically significant. Similarly, no sta-
tistically significant changes were detected in any of the 
other aberrations measured by wavefront analysis, with 
the exception of total coma aberration, which demonstrat-
ed significant postoperative increases at 3 and 6 months. 
MTF and PSF are objective methods used to assess the 
quality of vision. The overall MTF exhibited significant 
increases at all postoperative time points. In the MTF plot 
of corrections for lower-order aberrations (e.g., defocus and 
astigmatism), no statistically significant changes were de-
tected. Correction of defocus and astigmatism after re-
treatment may be attributed to the increase in total MTF. 
No statistically significant changes were found in HOAs, 
which corresponded to no indications of statistically sig-
nificant changes on the HO MTF plot. Likewise, PSF, 
which is closely related to visual function at night, exhibit-
ed no significant changes after the retreatment. 
Among higher order aberrations, coma aberration was 
increased while corneal asphericity and most ocular aber-
rations were not induced. The OPA algorithm is based on 
both wavefront and corneal topographic data to treat myo-
pia, and attempts to preserve the natural shape of the cor-
nea as much as possible. Nevertheless, worsened tear film 
dynamics and subclinical decentration after primary treat-
ment can interrupt precise ablation. Further, corneal or flap 
surface irregularities can negatively affect the retreatment 
results. In addition, we used ablation design software that 
only corrected ocular spherical aberration. HOAs, with the 
exception of coma aberrations, were maintained after the 
retreatment, while spherical aberration decreased. Corneal 
asphericity was likewise maintained. Overall, the visual 
quality of the patient is determined by various factors in-
cluding residual refractive error, higher order aberrations 
and corneal asphericity. Although coma aberration, one of 
the higher order aberrations, was increased, total MTF as 
an objective measurement of visual quality showed im-
provement in this study. 
OPA treatment is aimed at minimizing the induction of 
spherical aberrations and maintaining the prolate corneal 
shape. While postoperative visual acuity is an indicator of 
treatment efficacy, OPA retreatment will provide success-
ful visual recovery and optical quality improvement. In 
this study, corneal asphericity and most ocular aberrations 
were maintained successfully, which could contribute to 
the improved visual quality after the retreatment.
The drawbacks of the current study were the relatively 
small number of cases evaluated. The size of the patient 
group was insufficient to draw conclusions. However, con-
sidering the limited number of patients who are candidates 
for retreatment, we believe this study provides valuable 
data. Further, this is the first report of OPA retreatment for 
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residual refractive errors following laser surgery. Finally, 
the results indicate that OPA retreatment provided effec-
tive and reliable surgical outcomes, and objective visual 
performance revealed significant improvement after re-
treatment.
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